Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1721980

Corrigendum: The germinal center-tertiary lymphoid structure after neoadjuvant chemoimmunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression

Provisionally accepted
  • 1Department of Pathology, West China Hospital, Sichuan University, Chengdu, China
  • 2Department of Pathology, The First People's Hospital of Yunnan Province, Yunnan, Kunming, China
  • 3Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 4College of Physical Education and Health Science, Yi bin University, Yi bin, Sichuan, China

The final, formatted version of the article will be published soon.

Keywords: neoadjuvant chemoimmunotherapy, Lung squamous cell carcinoma, Prognostic biomarkers, tertiarylymphoid structures (TLSs), Neoadjuvant chemotherapy

Received: 10 Oct 2025; Accepted: 13 Oct 2025.

Copyright: © 2025 Li, Zhou, Huang, Chen, Yang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lili Jiang, 879876047@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.